Company profile for Kowa India

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Kowa Group is comprised of Kowa Company, Kowa Pharmaceutical Company & Kowa Shinyaku Company at its core, together with over 60 of their affiliated companies. Kowa India Pvt. Ltd., the Indian subsidiary of Kowa Co. Ltd., as a result of its already established business relations with Indian conglomerates, had succeeded in doing brilliantly since its inception in 2006. Kowa’s worldwide network backed by its rich heritage alwa...
Kowa Group is comprised of Kowa Company, Kowa Pharmaceutical Company & Kowa Shinyaku Company at its core, together with over 60 of their affiliated companies. Kowa India Pvt. Ltd., the Indian subsidiary of Kowa Co. Ltd., as a result of its already established business relations with Indian conglomerates, had succeeded in doing brilliantly since its inception in 2006. Kowa’s worldwide network backed by its rich heritage always had an impact on its services, quality, culture and the affirmative environment of the company. The growing proximity between Kowa and its Indian associates comes into focus not merely through commercial transactions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
India
Address
Address
408, Town Centre-1, Andheri Kurla Rd., Marol, Andheri (East), Mumbai 400 059
Telephone
Telephone
+91 22 2852 4680
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/esteve-and-kowa-pharmaceuticals-america-enter-into-an-exclusive-license-and-commercialization-agreement-for-rights-to-e-58425-for-the-potential-management-of-acute-pain1-9-in-the-united-states8-9-301280401.html

PRNEWSWIRE
04 May 2021

https://www.prnewswire.com/news-releases/esteve-and-kowa-pharmaceuticals-america-enter-into-an-exclusive-license-and-commercialization-agreement-for-rights-to-e-58425-for-the-potential-management-of-acute-pain1-9-in-the-united-states8-9-301280401.html

PRNEWSWIRE
03 May 2021

https://www.prnewswire.com/news-releases/kowa-achieves-goal-of-randomizing-10-000-patients-into-landmark-prominent-cardiovascular-outcomes-study-of-k-877-pemafibrate-301007144.html

PR NEWSWIRE
19 Feb 2020

https://www.law360.com/lifesciences/articles/966176

LAW361
21 Sep 2017

https://www.pharmacompass.com/pdf/news/livalo-pitavastatin-calcium-kowa-company-ltd-et-al-vhetero-drugs-limited-1497850887.pdf

PATENT LITIGATION
14 Jun 2017

http://www.pharmabiz.com/NewsDetails.aspx?aid=99845&sid=2

PHARMABIZ
17 Jan 2017

ABOUT THIS PAGE

Contact Kowa India and get a quotation

Kowa India is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Pitavastatin bulk offered by Kowa India

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty